Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23, Impact Factor: RJIF 5.98 | Free Publication Certificate
NAAS Rating: 5.23 new

Vol. 2, Issue 1 (2013)

Laboratory Monitoring of Psychotropic Medications: Physician and Pharmacist Collaboration

Abimbola Farinde
For many individuals who reside in state supported living centers for the developmentally disabled and/or mentally impaired,  there is the potential to be placed on a myriad of  psychotropic medications to treat behavioral, psychological, and psychiatric disturbances. Most of these psychotropic medications require continuous monitoring in order to assess for both effectiveness and possible side effect development. It is imperative that routine laboratory tests are performed for specific psychotropic medications (e.g., mood stabilizers and antipsychotic medication) and failure to monitor these drug therapies is recognized as one of the most frequent causes of preventable adverse drug events. The errors that are typically associated with laboratory monitoring appear to occur due to a lack of either baseline, follow-up laboratory monitoring, delay in action being taken to address abnormal laboratory results, or lack of appropriate collaboration between different health care professionals as it relates to medication management.
Pages: 86-88  |  1347 Views  11 Downloads

The Pharma Innovation Journal
How to cite this article:
Abimbola Farinde. Laboratory Monitoring of Psychotropic Medications: Physician and Pharmacist Collaboration. Pharma Innovation 2013;2(1):86-88.
Important Publications Links
The Pharma Innovation Journal

The Pharma Innovation Journal

Call for book chapter
The Pharma Innovation Journal